SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,902.59 138.36
( 0.19%)

Global Indices

Nasdaq

52,403.42 -403.65
(-0.76%)

Dow Jones

7,657.83 -36.69
(-0.48%)

Hang Seng

65,056.24 -86.54
(-0.13%)

Nikkei 225

10,611.90 -58.16
(-0.55%)

Forex

USD-INR

94.74 0.23
(0.24%)

EUR-INR

110.11 0.28
(0.26%)

GBP-INR

128.27 0.39
(0.30%)

JPY-INR

0.62 0.01
(0.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

IIFL Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

532636

INE530B01024

177.7400847

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IIFL

17.3

25744.06

EPS(TTM)

Face Value()

Div & Yield %

34.98

0.66

Back

Molbio Diagnostics reports consolidated net profit of Rs 58.75 crore in the June 2026 quarter

Sep 07,2026

Net profit of Molbio Diagnostics reported to Rs 58.75 crore in the quarter ended June 2026 as against net loss of Rs 23.71 crore during the previous quarter ended June 2025. Sales rose 309.57% to Rs 408.38 crore in the quarter ended June 2026 as against Rs 99.71 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	408.38	99.71	310
OPM %	24.63	-16.16	-
PBDT	92.98	-18.96	LP
PBT	75.91	-31.28	LP
NP	58.75	-23.71	LP

74,902.59 138.36 ( 0.19%)

52,403.42 -403.65 (-0.76%)

7,657.83 -36.69 (-0.48%)

65,056.24 -86.54 (-0.13%)

10,611.90 -58.16 (-0.55%)

94.74 0.23 (0.24%)

110.11 0.28 (0.26%)

128.27 0.39 (0.30%)

0.62 0.01 (0.94%)